Introduction of KAI1/CD82 gene suppressed metastatic ability of LNCaP human prostate cancer cells in SCID mouse model

Teikyo Medical Journal

Volumn 29, Issue 3, 2006, Pages 195-203

  Cho, Shuko ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene therapy; Inhibition of metastasis; KAI1 CD82 gene; LNCaP cells; Prostate cancer

Indexed keywords

CD82 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CELL STRAIN LNCAP; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; KAI1 GENE; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PELVIS LYMPH NODE; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33746895478     PISSN: 03875547     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Dong J-T, Lamb PW, Rinker-Schaeffer CW, et al. sKAI1, a Metastasis Suppressor sGene for Prostate Cancer on Human Chromosome 11p11.2. Science 1995; 268: 884-6.
2. Adachi M, Taki T, Ikei Y, et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small-cell lung cancer. Cancer Res 1996; 56: 1751-5.
3. Sato N, Gleave ME, Bruchovsky N, et al. Intermittent Androgen Suppression Delays Progression of Androgen-independent Regulation of Prostate Specific Antigen Gene in the LNCaP Prostate Tumour Model. J Steroid Biochem Molec Biol 1996; 58: 139-46.
4. Sato N, Gleave ME, Bruchovsky N, et al. A Metastatic and Androgen-sensitive Human Prostate Cancer Model Using Intraprostatic Inoculation of LNCaP Cells in SCID Mice. Cancer Res 1997; 57: 1584-9.
5. Ueda T, Ichikawa T, Tamaru J, et al. Expression of the KAI1 Protein in Benign Prostatic Hyperplasia and Prostate Cancer. Am J Pathol 1996; 149: 1435-40.
6. Miyake M, Adachi M, Huang C, et al. A novel molecular staging protocol for non-small cell lung cancer. Oncogene 1999; 18: 2397-404.
7. Takaoka A, Hinoda Y, Satoh S, et al. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 1998; 16: 1443-53.
8. Friess H, Guo X-Z, Berberat P, et al. Reduced KAI1 Expression in Pancreatic Cancer is Associated with Lymph Node and Distant Metastases. Int J Cancer 1998; 79: 349-55.
9. Hinoda Y, Adachi Y, Takaoka A, et al. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Cancer Letters 1998; 129: 229-34.
10. Uchida S, Shimada Y, Watanabe G, et al. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Brit J Cancer 1999; 79: 1168-73.
11. Huang C, Kohno N, Ogawa E, et al. Correlation of Reduction in MRP-1/CD9 and KAI1/CD82 Expression with Recurrences in Breast Cancer Patients. Am J Pathol 1998; 153: 973-83.
12. Vladutiu AO. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 1993; 93: 1-8.
13. Sigala S, Faraoni I, Bottini D, et al. Suppression of Telomerase, Reexpression of KAI1, and Abrogation of Tumorigenicity by Nerve Growth Factor in Prostate Cancer Cell Lines. Clin Cancer Res 1999; 5: 1211-8.